LoginSignup
SAN

Santhera Stock

StockStock
ISIN: CH1276028821
Ticker: SANN
CH1276028821
SANN

Price

Frequently asked questions

What is Santhera's market capitalization?

The market capitalization of Santhera is $123.34M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Santhera's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Santhera is 1.45. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Santhera?

Santhera's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.525. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Santhera's stock?

Currently, 1 analysts cover Santhera's stock, with a consensus target price of $34.02. Analyst ratings provide insights into the stock's expected performance.

What is Santhera's revenue over the trailing twelve months?

Over the trailing twelve months, Santhera reported a revenue of $128.82M.

What is the EBITDA for Santhera?

Santhera's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $65.46M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Santhera?

Santhera has a free cash flow of $53.61M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Santhera's stock?

The 5-year beta for Santhera is -0.07. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Santhera have, and what sector and industry does it belong to?

Santhera employs approximately 45 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Santhera's shares?

The free float of Santhera is 8.95M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $123.34M

5Y beta

 -0.07

EPS (TTM)

 $6.525

Free Float

 8.95M

P/E ratio (TTM)

 1.45

Revenue (TTM)

 $128.82M

EBITDA (TTM)

 $65.46M

Free Cashflow (TTM)

 $53.61M

Pricing

1D span
$9.507$9.802

Analyst Ratings

The price target is $34.02 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The Company focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

45

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH1276028821

Primary Ticker

SANN

Knockouts

Join the conversation
Sign upLogin